Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease

Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease

Aim.A comprehensive assessment of metabolic parameters in patients with non-alcoholic fatty liver disease and based on them the development of prognostic criteria for the development of liver fibrosis. Materials and methods.288 patients with non-alcoholic fatty liver disease at the stage of steat...

Full description

Bibliographic Details
Main Authors:	Ya. M. Vakhrushev, E. V. Suchkova, А. Р. Lukashevich
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2020-12-01
Series:	Терапевтический архив
Subjects:	non-alcoholic fatty liver disease logistic regression liver fibrosis prognostic criteria liver steatosis
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/60251/43413

Similar Items

Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
by: Yiyoung Kwon, et al.
Published: (2022-04-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
by: Marco Castellana, et al.
Published: (2021-04-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
by: Ma Ai Thanda Han
Published: (2020-09-01)

Knowing what’s out there: awareness of Non Alcoholic Fatty Liver Disease.
by: Vishal eGhevariya, et al.
Published: (2014-03-01)

The Prevalence of Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease in Ahvaz, Iran
by: Alireza Jahanshahi, et al.
Published: (2023-12-01)

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives
by: Georgiana-Diana Cazac, et al.
Published: (2023-04-01)

Effect of Microalgae and Macroalgae Extracts on Non-Alcoholic Fatty Liver Disease
by: Maitane González-Arceo, et al.
Published: (2021-06-01)

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
by: Claudia Mandato, et al.
Published: (2022-10-01)

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: George Chen, et al.
Published: (2023-09-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Asako Nogami, et al.
Published: (2023-02-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

The diagnostic conundrum in non-alcoholic fatty liver disease
by: Valerio Rosato, et al.
Published: (2020-10-01)

The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers
by: Zahra Safari, et al.
Published: (2023-05-01)

USING NON-INVASIVE BIOMARKERS AND PLACE OF CYTOKERATIN 18 IN DIAGNOSIS PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: N. V. Dynnyk
Published: (2016-04-01)

Non-Alcoholic Fatty Liver Disease in Children: Current View on Diagnostics and Treatment (Part I)
by: Yu.M. Stepanov, et al.
Published: (2015-04-01)

Role of Doppler ultrasonography of the splenoportal system in diagnosing early hepatic dysfunction in non-alcoholic fatty liver disease patients
by: Safeeq Ahmed Meeran S, et al.
Published: (2023-10-01)

Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-02-01)

The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease
by: Ya. M. Vakhrushev, et al.
Published: (2021-02-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development
by: Ya M Vakhrushev, et al.
Published: (2019-12-01)

Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2022-08-01)

Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States
by: Yuanhui Guo, et al.
Published: (2023-09-01)

<b>Analytical methods for evaluation of the fatty acid metabolism in rat liver
by: Eduardo Hideo Gilglioni, et al.
Published: (2018-11-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
by: Hirsh D. Trivedi, et al.
Published: (2021-09-01)

Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study
by: Assim A Alfadda, et al.
Published: (2022-01-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography
by: Monica Lupsor-Platon, et al.
Published: (2020-09-01)

Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP)
by: Lesmana CRA, et al.
Published: (2022-01-01)

Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2023-09-01)

Biochemical assessment of metabolic associated fatty liver disease
by: Guerra-Ruiz Armando R., et al.
Published: (2021-03-01)

Phospholipids in non-alcoholic fatty liver disease
by: V. V. Skvortsov, et al.
Published: (2022-04-01)

Liver Fibrosis in Primary Sjögren’s Syndrome
by: Theodoros Androutsakos, et al.
Published: (2022-06-01)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
by: Giovanni Tarantino, et al.
Published: (2024-02-01)

Ultrasound steatometry in patients with non-alcoholic fatty liver disease: pilot results
by: Darya Yu. Venidiktova, et al.
Published: (2019-04-01)